Emcure Pharmaceuticals Ltd 544210
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹1,432.30
- Day Range
- ₹1,432.65–1,459.80
- 52-Week Range
- ₹1,226.50–1,577.50
- Bid/Ask
- ₹0.00 / ₹0.00
- Market Cap
- ₹275.13 Bil
- Volume/Avg
- 5,529 / 44,304
Key Statistics
- Price/Earnings (Normalized)
- 49.71
- Price/Sales
- 4.11
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.emcure.com
Comparables
Valuation
|
Metric
|
544210
|
500288
|
000739
|
|---|---|---|---|
Price/Earnings (Normalized) | 49.71 | 37.41 | 18.32 |
Price/Book Value | — | 5.21 | 2.91 |
Price/Sales | 4.11 | 2.55 | 1.54 |
Price/Cash Flow | 32.30 | 34.57 | 9.69 |
Price/Earnings
544210
500288
000739
Financial Strength
|
Metric
|
544210
|
500288
|
000739
|
|---|---|---|---|
Quick Ratio | 0.75 | 0.87 | 0.97 |
Current Ratio | 1.33 | 2.21 | 1.30 |
Interest Coverage | 4.09 | 36.06 | 35.39 |
Quick Ratio
544210
500288
000739
Profitability
|
Metric
|
544210
|
500288
|
000739
|
|---|---|---|---|
Return on Assets (Normalized) | 8.13% | — | 7.96% |
Return on Equity (Normalized) | 21.12% | — | 16.93% |
Return on Invested Capital (Normalized) | 14.02% | — | 13.55% |
Return on Assets
544210
500288
000739
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Bwvjcpxh | Mhlz | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Zwdrryhb | Dchpztq | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Lzbvsvbf | Mxxh | $48.4 Bil | |||
| Viatris Inc
VTRS
| Dgqnpbg | Rctq | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Dqbjlll | Rwcb | $13.5 Bil | |||
| Catalent Inc
CTLT
| Qpkgpfrx | Srlzptb | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Zdwtftlr | Fmqsc | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Gjxhbdgc | Dtnb | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Dxggcrlsz | Hcljg | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Zzjcthrq | Pxz | $2.3 Bil |
United States